Every 424B that Aveanna Healthcare Holdings Inc. (AVAH) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow AVAH and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AVAH filings page.
Aveanna Healthcare Holdings Inc. (AVAH) has filed a prospectus supplement for the resale by selling stockholders of 15,000,000 shares of common stock at a public offering price of $11.75 per share. Aveanna will not receive any proceeds from this secondary offering, though it will bear offering expenses other than underwriting discounts and commissions.
The selling stockholders will receive net proceeds of $11.50 per share, or $172.5 million in total, with RBC Capital Markets acting as sole underwriter and holding a 30‑day option to purchase up to 2,250,000 additional shares. Aveanna had 218,152,927 shares outstanding as of July 4, 2026. After completion, the company will no longer be a Nasdaq-defined controlled company, though Bain Capital and J.H. Whitney affiliates are expected to retain significant influence with beneficial ownership of about 44.1% of common stock. Aveanna recently expanded its Private Duty Services segment by acquiring Family First Holding, LLC, a multi-state pediatric home care provider with 27 locations in seven states.
Aveanna Healthcare Holdings Inc. (AVAH) has registered a resale offering of 15,000,000 shares of common stock, all to be sold by existing selling stockholders; Aveanna will not receive any proceeds from these sales but will pay offering expenses other than underwriting discounts and commissions.
The underwriter has a 30‑day option to purchase up to 2,250,000 additional shares from certain Whitney-affiliated stockholders. Aveanna had 218,152,927 shares outstanding as of July 4, 202644.1% of the common stock and retain significant influence.
Aveanna Healthcare Holdings Inc. announced a secondary offering by selling stockholders of 10,000,000 shares of common stock at $9.00 per share. The company will not receive any proceeds from these sales; proceeds go to the selling stockholders. Underwriters have a 30‑day option to purchase up to 1,500,000 additional shares.
The pricing implies an aggregate public offering of $90,000,000, with underwriting discounts of $4,050,000 and proceeds to selling stockholders of $85,950,000. Aveanna’s common stock trades on Nasdaq as AVAH. Shares outstanding were 208,259,393 as of June 28, 2025.
Aveanna also provided preliminary, unaudited Q3 results: revenue of $616–$624 million, net income of $11–$15 million, and Adjusted EBITDA of $77–$81 million, each described as growth over the prior year’s third quarter. Delivery of shares is expected on or about October 23, 2025.
Aveanna Healthcare Holdings (AVAH) announced a secondary offering in which the Selling Stockholders are offering 10,000,000 shares of common stock. The company stated it will not receive any proceeds from these sales. The underwriters have a 30‑day option to purchase up to 1,500,000 additional shares at the public offering price, less underwriting discounts and commissions.
The company included a preliminary third‑quarter update: revenue is expected at $616–$624 million (up 21.0%–22.6% year over year), net income at $11–$15 million (up 125.7%–135.0%), and Adjusted EBITDA at $77–$81 million (up 61.0%–69.3%). These figures are unaudited and subject to completion of financial closing procedures. A 90‑day lock‑up applies to the company, Selling Stockholders, directors and officers, subject to customary exceptions.
Shares outstanding were 208,911,373 as of October 15, 2025; this is a baseline figure, not the amount being offered.